临床移植耐受进展(4)
7、 Inoue S, Aikawa M, Dobashi Y, et al. Donor-specific transfusion for kidney transplantation in the cyclosporine era. Transplant Proc,1996,28(3):1220-1221
8、 Middleton D, Martin J, Douglas J, et al. Transfusion of one HLA-DR antigen-matched blood to potential recipients of a renal allograft.Transplantation,1993,56:672-680
9、 Opelz G, Vanrenterghem Y, Kirste G et al. Prospective evaluation of pretransplant blood transfusion in cadaver kidney recipients.Transplantation,1997,63:964-967
, http://www.100md.com
10、 Monaco AP Use of donor-specific bone marrow to facilitate tolerance in clinical solid organ transplantation: Old facts and future prospects. Transplant Proc,1997,29:2983-2986
11、 Strazl TE, Demetris AJ, Murase N, et al. Cell migration, chimerism, and graft acceptance. Lancet,1992,339:1579-1582
12、 Starzl TE, Demetris AJ, Murase N, et al. Donor cell chimerism permitted by immunosuppressive drugs: A new view of organ transplantation. Immunol Today,1993,14:326-332
, http://www.100md.com
13、 Starzl TE, Demetris AJ, Trucco M, et al. Cell migration and chimerism after whole organ transplantation: The basis of graft acceptance. Hematology, 1993:1127-1152
14、 Starzl TE, Demetris AJ, Murase N, et al. The lost chord: Microchimerism and allograft survival. Immunol Today, 1996, 17:577-584
15、 Hiesse C, Samuel D,Blanchet P, et al. Results of combined kidney and liver transplantation in 22 patients: Renal frequecy and long-term allograft tolerance. 16th International Congress of the Transplantation Society, Barcelona,Spain,1996,p142(abstract)
, http://www.100md.com
16、 Barber WH, Mankin JA, Lascow DA, et al. Long -term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allografts recipients. Transplantation,1997,63:7-11
17、 Ricordi C, Karatzas T, Nery J, et al. High dose donor bone marrow infusions to enhance allograft survival. The effect of timing. Transplantation,1997,63:7-11
18、 Fontes P, Rao AS, Demetris AJ, et al. Augmentation with bone marrow of donor leucocyte migration for kidney, liver, hearts and pancreas islet transplantation. Lancet,1994,344:151-155
, 百拇医药
19、 Cuturi MC, Josien R, Doullard P, et al. Synthetic peptides derived from human MHC class I sequence delay allograft rejection in rodents and inhibit cell-mediated cytotoxity in vivo and in vitro. Immuno Rev, 1996,154:5-20
20、 Giral MC, Nguyen JM, Josien R et al. Decreased cytoxic activity of natural killer cells in kidney allogrft recipients treated with human HLA deride peptide. Transplantation,1991, 5:150
21、 Krensky AM, Clayberger C. Immunogic tolerance: Tailed antigen. Transplant Proc, 1996,28:2075-2077
, http://www.100md.com
22、 Wood KJ, Pearson TS, Darby C, et al. A potential target molecule for immunosuppressive therapy and tolerance induction. Transplantation, 1991,5:150
23、 Soullillou JP. Relevant targets for therapy with monoclonal antibody in allograft transplantation. Kidney Intern,1994,46:540-53
24、 Huang CE, Clovin RB, Delmonico FL, et al. A phase I trial of immunosuppression with anti-ICAM-1( CD54) mAB in renal recipients. Transplantation,1993, 55:766-773
25、 Hourmant M, Mauff BL, Meur YL, et al.Administration of monoclonal antibody in recipients of kidney transplantation(a pilot study). Transplantation ,1994,58:377-380, http://www.100md.com(王国良)
8、 Middleton D, Martin J, Douglas J, et al. Transfusion of one HLA-DR antigen-matched blood to potential recipients of a renal allograft.Transplantation,1993,56:672-680
9、 Opelz G, Vanrenterghem Y, Kirste G et al. Prospective evaluation of pretransplant blood transfusion in cadaver kidney recipients.Transplantation,1997,63:964-967
, http://www.100md.com
10、 Monaco AP Use of donor-specific bone marrow to facilitate tolerance in clinical solid organ transplantation: Old facts and future prospects. Transplant Proc,1997,29:2983-2986
11、 Strazl TE, Demetris AJ, Murase N, et al. Cell migration, chimerism, and graft acceptance. Lancet,1992,339:1579-1582
12、 Starzl TE, Demetris AJ, Murase N, et al. Donor cell chimerism permitted by immunosuppressive drugs: A new view of organ transplantation. Immunol Today,1993,14:326-332
, http://www.100md.com
13、 Starzl TE, Demetris AJ, Trucco M, et al. Cell migration and chimerism after whole organ transplantation: The basis of graft acceptance. Hematology, 1993:1127-1152
14、 Starzl TE, Demetris AJ, Murase N, et al. The lost chord: Microchimerism and allograft survival. Immunol Today, 1996, 17:577-584
15、 Hiesse C, Samuel D,Blanchet P, et al. Results of combined kidney and liver transplantation in 22 patients: Renal frequecy and long-term allograft tolerance. 16th International Congress of the Transplantation Society, Barcelona,Spain,1996,p142(abstract)
, http://www.100md.com
16、 Barber WH, Mankin JA, Lascow DA, et al. Long -term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allografts recipients. Transplantation,1997,63:7-11
17、 Ricordi C, Karatzas T, Nery J, et al. High dose donor bone marrow infusions to enhance allograft survival. The effect of timing. Transplantation,1997,63:7-11
18、 Fontes P, Rao AS, Demetris AJ, et al. Augmentation with bone marrow of donor leucocyte migration for kidney, liver, hearts and pancreas islet transplantation. Lancet,1994,344:151-155
, 百拇医药
19、 Cuturi MC, Josien R, Doullard P, et al. Synthetic peptides derived from human MHC class I sequence delay allograft rejection in rodents and inhibit cell-mediated cytotoxity in vivo and in vitro. Immuno Rev, 1996,154:5-20
20、 Giral MC, Nguyen JM, Josien R et al. Decreased cytoxic activity of natural killer cells in kidney allogrft recipients treated with human HLA deride peptide. Transplantation,1991, 5:150
21、 Krensky AM, Clayberger C. Immunogic tolerance: Tailed antigen. Transplant Proc, 1996,28:2075-2077
, http://www.100md.com
22、 Wood KJ, Pearson TS, Darby C, et al. A potential target molecule for immunosuppressive therapy and tolerance induction. Transplantation, 1991,5:150
23、 Soullillou JP. Relevant targets for therapy with monoclonal antibody in allograft transplantation. Kidney Intern,1994,46:540-53
24、 Huang CE, Clovin RB, Delmonico FL, et al. A phase I trial of immunosuppression with anti-ICAM-1( CD54) mAB in renal recipients. Transplantation,1993, 55:766-773
25、 Hourmant M, Mauff BL, Meur YL, et al.Administration of monoclonal antibody in recipients of kidney transplantation(a pilot study). Transplantation ,1994,58:377-380, http://www.100md.com(王国良)